206 related articles for article (PubMed ID: 29941569)
1. Ionophoric effects of the antitubercular drug bedaquiline.
Hards K; McMillan DGG; Schurig-Briccio LA; Gennis RB; Lill H; Bald D; Cook GM
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7326-7331. PubMed ID: 29941569
[TBL] [Abstract][Full Text] [Related]
2. Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis.
Salifu EY; Agoni C; Olotu FA; Dokurugu YM; Soliman MES
J Cell Biochem; 2019 Sep; 120(9):16108-16119. PubMed ID: 31125144
[TBL] [Abstract][Full Text] [Related]
3. TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug's Uncoupler Activity.
Sarathy JP; Ragunathan P; Cooper CB; Upton AM; Grüber G; Dick T
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712198
[TBL] [Abstract][Full Text] [Related]
4. TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of
Sarathy JP; Ragunathan P; Shin J; Cooper CB; Upton AM; Grüber G; Dick T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358589
[TBL] [Abstract][Full Text] [Related]
5. Targeting bacterial energetics to produce new antimicrobials.
Hards K; Cook GM
Drug Resist Updat; 2018 Jan; 36():1-12. PubMed ID: 29499834
[TBL] [Abstract][Full Text] [Related]
6. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
[TBL] [Abstract][Full Text] [Related]
7. Current Perspective of ATP Synthase Inhibitors in the Management of the Tuberculosis.
Divita KM; Khatik GL
Curr Top Med Chem; 2021; 21(18):1623-1643. PubMed ID: 34517802
[TBL] [Abstract][Full Text] [Related]
8. Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.
Salifu EY; Agoni C; Olotu FA; Soliman MES
Comput Biol Chem; 2020 Apr; 85():107204. PubMed ID: 31981966
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of mycobacterial ATP synthase inhibition by squaramides and second generation diarylquinolines.
Courbon GM; Palme PR; Mann L; Richter A; Imming P; Rubinstein JL
EMBO J; 2023 Aug; 42(15):e113687. PubMed ID: 37377118
[TBL] [Abstract][Full Text] [Related]
10. Variations of the Mycobacterium abscessus F-ATP synthase subunit a-c interface alter binding and potency of the anti-TB drug bedaquiline.
Krah A; Ragunathan P; Bond PJ; Grüber G
Biochem Biophys Res Commun; 2024 Jan; 690():149249. PubMed ID: 38000294
[TBL] [Abstract][Full Text] [Related]
11. Bedaquiline inhibits the yeast and human mitochondrial ATP synthases.
Luo M; Zhou W; Patel H; Srivastava AP; Symersky J; Bonar MM; Faraldo-Gómez JD; Liao M; Mueller DM
Commun Biol; 2020 Aug; 3(1):452. PubMed ID: 32814813
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal mode of action of bedaquiline.
Hards K; Robson JR; Berney M; Shaw L; Bald D; Koul A; Andries K; Cook GM
J Antimicrob Chemother; 2015 Jul; 70(7):2028-37. PubMed ID: 25754998
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the anti-tuberculous drug bedaquiline with artificial membranes and rat erythrocytes.
Belosludtsev KN; Penkov NV; Tenkov KS; Talanov EY; Belosludtseva NV; Agafonov AV; Stepanova AE; Starinets VS; Vashchenko OV; Gudkov SV; Dubinin MV
Chem Biol Interact; 2019 Feb; 299():8-14. PubMed ID: 30496736
[TBL] [Abstract][Full Text] [Related]
14. A Mycobacterium tuberculosis cytochrome bd oxidase mutant is hypersensitive to bedaquiline.
Berney M; Hartman TE; Jacobs WR
mBio; 2014 Jul; 5(4):e01275-14. PubMed ID: 25028424
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effect of a Novel ATP-Synthase Inhibitor Bedaquiline in Cerebral Ischemia-Reperfusion Injury.
Umbrasas D; Arandarcikaite O; Grigaleviciute R; Stakauskas R; Borutaite V
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575875
[TBL] [Abstract][Full Text] [Related]
16. A tale of two inhibitors: diarylquinolines and squaramides.
Chen J; Ekiert DC
EMBO J; 2023 Aug; 42(15):e114912. PubMed ID: 37435707
[TBL] [Abstract][Full Text] [Related]
17. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism.
Koul A; Vranckx L; Dhar N; Göhlmann HW; Özdemir E; Neefs JM; Schulz M; Lu P; Mørtz E; McKinney JD; Andries K; Bald D
Nat Commun; 2014 Feb; 5():3369. PubMed ID: 24569628
[TBL] [Abstract][Full Text] [Related]
18. Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase.
Krah A; Grüber G; Bond PJ
Curr Res Struct Biol; 2022; 4():278-284. PubMed ID: 36186842
[TBL] [Abstract][Full Text] [Related]
19. Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds.
He C; Preiss L; Wang B; Fu L; Wen H; Zhang X; Cui H; Meier T; Yin D
ChemMedChem; 2017 Jan; 12(2):106-119. PubMed ID: 27792278
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria.
Martin A; Godino IT; Aguilar-Ayala DA; Mathys V; Lounis N; Villalobos HR
J Med Microbiol; 2019 Aug; 68(8):1137-1139. PubMed ID: 31210631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
